FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Voyageur Pharmaceuticals Ltd. Stock AnalysisComprehensive stock analysis for Voyageur Pharmaceuticals Ltd. (VM.V) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisVM.V
VM.V
Voyageur Pharmaceuticals Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
VM.V
Home🔹Stocks🔹Voyageur Pharmaceuticals Ltd.

Voyageur Pharmaceuticals Ltd.

FRC Coverage
VM.V•TSXV

Voyageur Pharmaceuticals Ltd.

FRC Coverage
VM.V•TSXV
Sentiment

Your view on VM.V

Sentiment
Your view
VM.V
Voyageur Pharmaceuticals Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
VM.V
Company Overview

Overview

What the company does, where it operates, and who runs it.

*Voyageur Pharmaceuticals Ltd. has paid FRC a fee for research coverage and distribution of reports.

About Voyageur Pharmaceuticals Ltd.

Industry
Drug Manufacturers-Specialty & Generic
Sector
Healthcare
CEO
Brent Willis Bsc.Eng
Headquarters
339–50th Avenue SE, Calgary, AB, CA
Industry
Drug Manufacturers-Specialty & Generic
Sector
Healthcare
CEO
Brent Willis Bsc.Eng
Headquarters
339–50th Avenue SE, Calgary, AB, CA
Description

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Infographics

Visual summary of the business at a glance.

FRC Research

Research Reports

FRC analyst coverage and recommendations.

Past Reports

Historical coverage archive.

Analyst Notes

Ongoing commentary and updates from FRC analysts.

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News